Collaboration for AIDS Vaccine Discovery (CAVD)

United States of America (USA)

1 October 2016 - 30 September 2017

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Collaboration for AIDS Vaccine Discovery (CAVD) published between 1 October 2016 - 30 September 2017 which are tracked by the Nature Index.

Hover over the donut graph to view the WFC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Research collaboration: Collaboration for AIDS Vaccine Discovery (CAVD) is a research collaboration whose article contributions are accrued to its participating partner institutions.

Note: Articles may be assigned to more than one subject area.

AC FC WFC
4 0.80 0.80

Outputs by subject (WFC)

Subject AC FC WFC
Life Sciences 4 0.80 0.80

1 October 2016 - 30 September 2017

International vs. domestic collaboration by WFC

  • 27.66% Domestic
  • 72.34% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 international collaborators by WFC (5 total)

  • Collaboration for AIDS Vaccine Discovery (CAVD), United States of America (USA)
  • Foreign institution
  1. HIV Vaccine Translational Research Laboratory (HVTR), India (1.75)
    0.50
    1.25
  2. Translational Health Science and Technology Institute (THSTI), India (1.13)
    0.50
    0.63
  3. Free University of Berlin (FU Berlin), Germany (0.80)
    0.80
    0
  4. Humboldt University of Berlin (HU Berlin), Germany (0.80)
    0.80
    0
  5. University of Toronto (U of T), Canada (0.20)
    0.17
    0.03

Note: Collaboration is determined by the weighted fractional count (WFC), which is listed in parentheses.

Participating institutions

Collaboration for AIDS Vaccine Discovery (CAVD) is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Return to institution outputs